Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Journal of Medical Virology
|
January 23, 2015
Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse
Anita Kohli, Emily Funk, Peter Burbelo, et al.
Journal of the National Cancer Institute
|
June 5, 2024
Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035
Ashvita Garg, Haluk Damgacioglu, Keith Sigel, et al.
The Journal of Antimicrobial Chemotherapy
|
May 15, 2015
Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin
Joseph E Rower, Eric G Meissner, Leah C Jimmerson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 27, 2017
IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling
Adeola A Obajemu, Nina Rao, Kari A Dilley, et al.
BMC Health Services Research
|
May 9, 2022
Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study
Charles Muiruri, Amy Corneli, Linda Cooper, et al.
Journal of Clinical Pharmacology
|
June 29, 2016
Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels
Leah C Jimmerson, Thomas J Urban, Aimee Truesdale, et al.
Hepatology (Baltimore, Md.)
|
September 10, 2014
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients
Eric G Meissner, Yu-Jin Lee, Anu Osinusi, et al.
AIDS Patient Care and Stds
|
June 13, 2024
Specialty Care Referral for Underrepresented Minorities Living with HIV in the United States: Experiences, Barriers, and Facilitators
Charles Muiruri, Carrie Dombeck, Teresa Swezey, et al.
Open Forum Infectious Diseases
|
September 30, 2020
Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?
Nwora Lance Okeke, Katherine R Schafer, Eric G Meissner, et al.
Vaccine
|
January 2, 2016
Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination
Zhenwu Luo, Lei Ma, Lumin Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Journal of Medical Virology
|
January 23, 2015
Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse
Anita Kohli, Emily Funk, Peter Burbelo, et al.
Journal of the National Cancer Institute
|
June 5, 2024
Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035
Ashvita Garg, Haluk Damgacioglu, Keith Sigel, et al.
The Journal of Antimicrobial Chemotherapy
|
May 15, 2015
Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin
Joseph E Rower, Eric G Meissner, Leah C Jimmerson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 27, 2017
IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling
Adeola A Obajemu, Nina Rao, Kari A Dilley, et al.
BMC Health Services Research
|
May 9, 2022
Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study
Charles Muiruri, Amy Corneli, Linda Cooper, et al.
Journal of Clinical Pharmacology
|
June 29, 2016
Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels
Leah C Jimmerson, Thomas J Urban, Aimee Truesdale, et al.
Hepatology (Baltimore, Md.)
|
September 10, 2014
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients
Eric G Meissner, Yu-Jin Lee, Anu Osinusi, et al.
AIDS Patient Care and Stds
|
June 13, 2024
Specialty Care Referral for Underrepresented Minorities Living with HIV in the United States: Experiences, Barriers, and Facilitators
Charles Muiruri, Carrie Dombeck, Teresa Swezey, et al.
Open Forum Infectious Diseases
|
September 30, 2020
Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?
Nwora Lance Okeke, Katherine R Schafer, Eric G Meissner, et al.
Vaccine
|
January 2, 2016
Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination
Zhenwu Luo, Lei Ma, Lumin Zhang, et al.
Page
of 8